利用线虫模型研究紫娟普洱茶抗阿尔兹海默病的作用机制
[Abstract]:Alzheimer's disease is a kind of neurodegenerative disease. The main pathological features of Alzheimer's disease are the deposition of senile plaques and the tangles of nerve fibers in the brain. However, the mechanism of Alzheimer's disease is still unclear. With the acceleration of population aging, the number of people suffering from Alzheimer's disease is also increasing year by year. Therefore, it is urgent to develop a drug or treatment to reduce the incidence of Alzheimer's disease and delay the occurrence and development of Alzheimer's disease. The current treatment of Alzheimer's disease is mainly cholinesterase inhibitors, such drugs can only alleviate the symptoms of patients, can not achieve the basic purpose of treatment. So researchers are working on new drugs that can treat Alzheimer's disease. A large number of studies have shown that natural products with antioxidant effects may have the effect of treating Alzheimer's disease, and natural products, as drugs derived from natural benefits themselves, have a good prospect of application. Therefore, natural products were screened for anti-Alzheimer's disease in this paper. Although the pathogenesis of Alzheimer's disease is still unclear, several hypotheses, especially the A 尾 cascade hypothesis, have been accepted by the public. Therefore, the drug screening model we selected is A 尾 CL4176 transgenic nematode strain of Caenorhabditis elegans,C.elegans. Screening of drugs against Alzheimer's disease based on A 尾 hypothesis. After a series of screening, we found that a variety of natural products have a better effect, we choose Zijuan Puer tea powder as the main research object. Three dosages were designed, 0.1 mg / ml 0.2 mg / ml and 0.4 mg / ml respectively. For CL4176 transgenic nematodes, the three concentrations could delay the paralysis of nematodes and present a concentration-dependent manner. Therefore, the mechanism of 0.4mg/ml powder was studied. The effects of EGCG and proanthocyanidins were verified. It was found that the main components of 0.4mg/ml were not the two components mentioned above. At first, the effect level of Puer tea powder from 0.4mg/ml was detected, and it was found that 0.4mg/ml did not affect the level of A 尾 m RNA in CL4176 nematode, but could inhibit the deposition of A 尾, indicating that the drug acted on the posttranscriptional level. Secondly, the pretreatment of CL4176 nematodes showed that the treatment group still had the effect of delaying the paralysis of nematodes. Therefore, some transcription factors related to stress resistance in nematodes were detected by qPCR. We found that sir2.1 was upregulated obviously. TJ356 nematode was used to track the effect of 0.4mg/ml 's Pu'er tea powder on the nucleation of DAF-16. The results showed that the nucleation of DAF-16 was promoted after administration. SOD-3::GFP co-expressed nematodes were used to further confirm the necessity of DAF-16 transcriptional activity for nematode resistance to oxidative stress. According to the effect of A 尾 on the increase of oxidative stress in nematode, the content of ROS and the change of SOD activity in CL4176 nematodes were determined. We speculate that this may increase the ability of nematodes to resist oxidative stress after administration. Finally, the toxicity of Pu'er tea was detected, and it was found that Zijuan Pu'er tea could delay the paralysis of nematodes in a safe dose. To sum up, the drug against Alzheimer's disease was screened by Rhizoma elegans. The tea powder of Zjuanjuan Pu'er can inhibit A 尾 toxicity and delay the paralysis of nematodes. The inhibition may be related to the ability of nematode to resist the oxidative stress induced by A 尾 and to inhibit the deposition of A 尾.
【学位授予单位】:吉林大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R285.5;R-332
【相似文献】
相关期刊论文 前10条
1 姚佳红,李辉;阿尔兹海默病危险因素的病例对照研究[J];中国公共卫生;2002年02期
2 刘坤梅,丁宛琼;早发家族阿尔兹海默病1个家系报道[J];职业卫生与病伤;2002年04期
3 李电东;第九届国际阿尔兹海默病会议在美国费城召开[J];中国新药杂志;2004年08期
4 孙磊;杨莹;窦彩艳;;阿尔兹海默病治疗的研究进展[J];医学信息(中旬刊);2010年07期
5 王艳平;翟静波;朱芳;张雯雯;杨晓娟;曲成毅;;社区老年人阿尔兹海默病患病及影响因素分析[J];中国公共卫生;2011年07期
6 翟月;;线粒体平衡在阿尔兹海默病中的作用[J];中国科技信息;2012年10期
7 张于;程伟;;中西医治疗阿尔兹海默病的研究现状[J];中医临床研究;2012年13期
8 郑亚楠;甘小荣;;我国阿尔兹海默病相关心理学研究综述[J];中国实用医药;2013年08期
9 谢岚;艾华;;运动对阿尔兹海默病影响的研究进展[J];中国运动医学杂志;2013年09期
10 左萍萍;β淀粉样肽代谢与阿尔兹海默病[J];标记免疫分析与临床;2001年01期
相关会议论文 前6条
1 苗雅;何婷;钟远;;阿尔兹海默病与磷酸二酯酶4相关性的研究进展(综述)[A];第三届江浙沪三地老年医学高峰论坛暨2012年浙江省老年医学学术年会论文集[C];2012年
2 曼淑梅;陈誉华;;阿尔兹海默病人外周血免疫细胞穿过血脑屏障能力分析[A];中国细胞生物学学会第八届会员代表大会暨学术大会论文摘要集[C];2003年
3 孙一_,
本文编号:2223021
本文链接:https://www.wllwen.com/yixuelunwen/jichuyixue/2223021.html